Emetine for Viral Outbreaks (a.k.a. EVOLVE Antiviral Initiative) | MicrobiomeTrials← Back to trialsNCT07016321
Emetine for Viral Outbreaks (a.k.a. EVOLVE Antiviral Initiative)
RecruitingPHASE2, PHASE3INTERVENTIONAL
Trial Details
Start: 2026-06-25Est. Completion: 2029-03-01
Enrollment target: 600 participants Locations- Johns Hopkins University, Division of Infectious Disease, Baltimore, Maryland, United States
- Bharatpur Hospital, Bharatpur-10, Chitwan, Nepal
Other microbiome trials you might be interested in
DengueDengue Hemorrhagic FeverIntestinal DiseaseAscitesDengue With Warning SignsGut Microbiome
Dengue infections are imposing an increasing global burden of disease, particularly in tropical countries such as Bangla…
Chittagong, BangladeshEst. completion Jan 31, 2027
Anogenital HerpesCOVID-19Herpes Labialis
Background:
\- Viral infections are an important cause of illness and death in hospitalized patients as well as outpati…
Bethesda, United States